Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Call to discuss its First Quarter 2024 Financial Results and Business Updates.
Bob Azelby to join Cardinal Health Board of Directors marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Cardinal Health (NYSE: CAH) announced today that its Board of Directors has elected Robert "Bob" Azelby as an independent director, effective.
LONDON, Jan. 10, 2024 Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the appointment of Robert W..
Tech Moves: Eliem CEO out amid layoffs; Rokt taps Amazon vet to lead new Seattle office; and more geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.